MetaCap

Azora Therapeutics Financial Statements

NASDAQ: AZRHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.85-0.02 (-0.52%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Azora Therapeutics revenue and earnings

Azora Therapeutics reported a net loss of $8.0 million, compared with a loss of $13.2 million a year earlier. Diluted earnings per share came in at -$11.93.

Summary generated from market data by MetaCap's automated system. Methodology

Azora Therapeutics income statement (annual)

Azora Therapeutics annual income statement
Fiscal year (USD)FY 20252025-12-31FY 20242024-12-31FY 20232023-12-31FY 20222022-12-31FY 20212021-12-31FY 20202020-12-31FY 20192019-12-31FY 20182018-12-31FY 20172017-12-31
Operating Expenses7.80M8.28M6.89M10.86M19.29M10.93M8.24M6.99M995.29K
Research & Development2.62M3.23M1.27M1.95M8.40M5.85M3.97M368.46K182.11K
Operating Income-7.80M-8.28M-6.89M-10.86M-19.29M-10.93M-8.24M-6.99M-995.29K
Other Income (Expense)-177.71K-4.91M-113.94K63.34K-228.68K34.99K-346.53K-4.64M-144.17K
Pretax Income-7.98M-13.20M-7.00M-10.80M-19.52M-10.89M-8.59M-11.63M-1.14M
Income Tax———-502-94.08K————
Net Income-7.98M-13.20M-5.12M-12.73M-19.42M-10.89M-8.59M-11.63M-1.14M
Net Income growth (YoY)—————————
EPS (Basic)-11.93-68.01-3.60-12.71-1.04-0.87-0.87-2.44-0.35
EPS (Diluted)-11.93-68.01-3.60-12.71-1.04-0.87-0.87-2.44-0.35
Shares Outstanding (Basic)668.63K194.06K—25.04M18.59M12.46M9.85M4.76M3.26M
Shares Outstanding (Diluted)668.63K194.06K1.42M1.00M18.59M12.46M9.85M243.18K174.28K

This table shows 9 annual periods of Azora Therapeutics's income statement, from FY 2025 back to FY 2017, across 11 line items including operating expenses, research & development, operating income. Values in USD; B = billions, M = millions. Fiscal periods follow AZR's reporting calendar. What is a income statement?

More financial data